Last week, OTCs were in Action in Canada, where Sucanon has been evaluated by regulatory authorities, and is now a licensed natural health product for treating Type 2 diabetes.
Marketed by PharmaRoth Laboratories, Sucanon is an insulin sensitiser, lowering a patient’s blood sugar by increasing the muscle, fat and liver’s sensitivity to the body’s own naturally produced insulin. The product is also available as an OTC in Mexico, but has Rx status in China and Peru.
Last year, the US FDA denied PharmaRoth’s New Dietary Ingredient application for Sucanon to be sold as a nutraceutical. According to the US agency, the active ingredients, derived from a dried root and a form of molybdenum, should be classified as a drug.
OTCs in Action will be watching with interest this product’s expansion to various countries as PharmaRoth seeks to give diabetics access to safe and effective treatment. The brand’s tagline is:
Sucanon … Diabetes is not curable but is treatable … enjoy life.